OncoMed Pharmaceuticals, Inc. Product Market Analysis,Share Pipeline 2014

OncoMed
Pharmaceuticals, Inc.
- Product Pipeline
Review - 2014
www.bigmarketresearch.com

Report Description
Acquired (Autoimmune) Hemolytic Anemia
Summary
Global Markets Direct’s, ‘OncoMed Pharmaceuticals, Inc. - Product Pipeline Review -
2014’, provides an overview of the OncoMed Pharmaceuticals, Inc.’s pharmaceutical
research and development focus.
This report provides comprehensive information on the current therapeutic
developmental pipeline of OncoMed Pharmaceuticals, Inc.’s, complete with comparative
analysis at various stages, therapeutics assessment by drug target, mechanism of action
(MoA), route of administration (RoA) and molecule type. It also reviews latest updates,
and featured news and press releases, along with special features on late-stage and
discontinued projects.
Get More Details At: http://www.bigmarketresearch.com/oncomed-pharmaceuticalsinc-product-pipeline-review-2014-market

Report Description

Report Description
Scope
- The report provides brief overview of OncoMed Pharmaceuticals, Inc. including
business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of OncoMed Pharmaceuticals, Inc.’s human
therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key
pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the OncoMed Pharmaceuticals, Inc.’s pipeline products
Enquire about report - http://www.bigmarketresearch.com/report-enquiry/152198

Report Description
Reasons to buy
- Evaluate OncoMed Pharmaceuticals, Inc.’s strategic position with total access to
detailed information on its product pipeline
- Assess the growth potential of OncoMed Pharmaceuticals, Inc. in its therapy areas of
focus
- Identify new drug targets and therapeutic classes in the OncoMed Pharmaceuticals,
Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those
areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill
portfolio gaps
- Develop strategic initiatives by understanding the focus areas of OncoMed
Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities

Report Description
Reasons to buy
- Identify emerging players with potentially strong product portfolio and create
effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of
OncoMed Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective
partners with the most attractive projects to enhance and expand business potential
and scope
- Explore the dormant and discontinued projects of OncoMed Pharmaceuticals, Inc. and
identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Content
• List of Tables
• List of Figures
• OncoMed Pharmaceuticals, Inc. Snapshot
• OncoMed Pharmaceuticals, Inc. Overview
• Key Information
• Key Facts
• OncoMed Pharmaceuticals, Inc. - Research and Development Overview
• Key Therapeutic Areas
• OncoMed Pharmaceuticals, Inc. - Pipeline Review
• Pipeline Products by Stage of Development
• Pipeline Products - Monotherapy
• Pipeline Products - Partnered Products
Get complete TOC here @ http://www.bigmarketresearch.com/oncomed-pharmaceuticalsinc-product-pipeline-review-2014-market

FOR MORE DETAILS
Visit us at :
http://www.bigmarketresearch.com/oncomedpharmaceuticals-inc-product-pipeline-review-2014-market
Stay With Us:
TELEPHONE: +1 (855) 711-1555
E-MAIL: sales@bigmarketresearch.com
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States